Meeting
2015 Breast Cancer Symposium
Locoregional failure rates after mastectomy for breast cancer patients with T1-2 tumors and axillary nodal microscopic metastases.
Authors
Lonika Majithia
The Ohio State University Wexner Medical Center, Columbus, OH
Lonika Majithia , Jose Bazan , Allison Marie Quick , Alicia Maria Terando , Doreen Marie Agnese , Ewa Mrozek , William Blair Farrar , Julia R. White
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Risk Assessment, Prevention, Early Detection, Screening, and Local/Regional Therapy
Track
Local/Regional Therapy,Systemic Therapy,Risk Assessment, Prevention, Early Detection, and Screening
Sub Track
Management of Node-Positive Disease
Citation
J Clin Oncol 33, 2015 (suppl 28S; abstr 64)
DOI
10.1200/jco.2015.33.28_suppl.64
Abstract #
64
Poster Bd #
J4
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Disease-free survival (DFS) as a surrogate for overall survival (OS) in patients (pts) with HR+/HER2− early breast cancer (EBC): A correlation analysis.
First Author: Michael Untch
Poster
2023 ASCO Annual Meeting
Phase II study on feasibility of sentinel lymph node biopsy for ycN0 patients treated with primary chemotherapy in cT1-3N1M0 breast cancer (SHARE study).
First Author: Rikiya Nakamura
Poster
2022 ASCO Annual Meeting
Ovarian function suppression is not indispensable in patients with early breast cancer who are older than age 40.
First Author: Jianqiao Xian
Poster
2020 ASCO Virtual Scientific Program
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer.
First Author: Matthew Loft